The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Drug-Induced Liver Injury
Abstract
Drug-induced hepatotoxicity is a frequent cause of liver injury. The predominant clinical presentation is acute hepatitis and/or cholestasis, although almost any clinical pathological pattern of acute or chronic liver disease can occur. The pathogenesis of drug-induced liver disease usually involves the participation of the parent drug or metabolites that either directly affect the cell biochemistry or elicit an immune response. Each hepatotoxin is associated with a characteristic signature regarding the pattern of injury and latency. However, some drugs may exhibit >1 signature. Susceptibility to drug-induced hepatotoxicity is also influenced by genetic and environmental risk factors. Unpredictable, low-frequency, idiosyncratic reactions often occur on a background of a higher rate of mild asymptomatic liver injury and, although difficult to predict, they may be detected by monitoring serum alanine aminotransferase levels. Recent and future advances in toxicogenomics and proteomics should improve the identification of risk factors and the understanding of idiosyncratic hepatotoxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820
Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.
Shear, N. H., & Spielberg, S. P. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113798 · Cited by 687
Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver
Maddrey, W. C. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70192-2 · Cited by 646
Schiff's diseases of the liver
HERRINE, S. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70521-4 · Cited by 440
Idiosyncratic drug reactions: the reactive metabolite syndromes
Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331
Mechanisms of liver cell injury
Kaplowitz, N. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80414-6 · Cited by 311
Self-citationUetrecht, J. P. (1999) · Chemical Research in Toxicology · doi:10.1021/tx980249i · Cited by 304
Drug-Induced Liver Disorders: Implications for Drug Development and Regulation
Kaplowitz, N. (2001) · Drug Safety · doi:10.2165/00002018-200124070-00001 · Cited by 260
Self-citationDeLeve, L. D., Wang, X., Kuhlenkamp, J. F., & Kaplowitz, N. (1996) · Hepatology · doi:10.1002/hep.510230326 · Cited by 248
Self-citationBiochemical and Cellular Mechanisms of Toxic Liver Injury
Kaplowitz, N. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30100 · Cited by 239
Self-citationOdin, J. A., Huebert, R. C., Casciola-Rosen, L., LaRusso, N. F., & Rosen, A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200110716 · Cited by 220
Zimmerman, H. J. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70097-0 · Cited by 186
Toxicogenomics and drug discovery: will new technologies help us produce better drugs?
Ulrich, R., & Friend, S. H. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd710 · Cited by 182
Immune-mediated drug-induced liver disease
Liu, Z.-X., & Kaplowitz, N. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00025-9 · Cited by 170
Self-citationPlasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis
Robin, M., Roy, M. L., Descatoire, V., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82329-x · Cited by 129
Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
Moradpour, D., Altorfer, J., Flury, R., Greminger, P., Meyenberger, C. M., Jost, R., & Schmid, M. (1994) · Hepatology · doi:10.1002/hep.1840200610 · Cited by 123
Drug-Protein Conjugation and its Immunological Consequences
Park, B. K., & Kitteringham, N. R. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991445 · Cited by 114
Anti-tuberculosis medication and the liver: dangers and recommendations in management
Thompson, N., Caplin, M. E., Hamilton, M., Gillespie, S. H., Clarke, S. W., Burroughs, A. K., & McIntyre, N. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08081384 · Cited by 99
Presence of Functional Cytochrome P–450 on Isolated Rat Hepatocyte Plasma Membrane
Loeper, J., Descatoire, V., Maurice, M., Beaune, P. H., Feldmann, G., Larrey, D. G., & Pessayre, D. (1990) · Hepatology · doi:10.1002/hep.1840110521 · Cited by 96
Tarazi, E. M., Harter, J. G., Zimmerman, H. J., Ishak, K. G., & Eaton, R. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90428-f · Cited by 92
Immunotoxicology of the liver: adverse reactions to drugs
Beaune, P. H., & Lecoeur, S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80495-3 · Cited by 51
Kaplowitz, N. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70094-5 · Cited by 47
Self-citationDrug metabolism and hepatotoxicity.
Tredger, J. M., & Davis, M. R. (1991) · Gut · doi:10.1136/gut.32.suppl.s34 · Cited by 29
Mechanisms of Cell Death and Relevance to Drug Toxicity
Dara, L., Han, D., & Kaplowitz, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00006-6 · Cited by 15
Self-citation
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Navarro, V. J., & Senior, J. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052270 · Cited by 811
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Abboud, G., & Kaplowitz, N. (2007) · Drug Safety · doi:10.2165/00002018-200730040-00001 · Cited by 479
Self-citationIdiosyncratic Adverse Reactions to Antiepileptic Drugs
Zaccara, G., Franciotta, D., & Perucca, E. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01041.x · Cited by 364
Metadata
- Authors
- Kaplowitz, N.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-03-01
- Volume
- 38
- Issue
- Supplement_2
- Pages
- S44-S48
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2111923125
- Cited by
- 402
- References
- 24
- FWCI
- 11.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.